Category Archives: Molecular Medicine

Open Access

Research Article

These authors contributed equally to this work

This study provides molecular insights into the anterior gradient 2 (AGR2) mode of action in the endoplasmic reticulum (ER) with an emphasis on the regulation of AGR2 dimers. Dysregulation of AGR2 dimer formation leads to inflammation as seen in inflammatory bowel disease (IBD) and Crohn's disease.

This study provides molecular insights into the anterior gradient 2 (AGR2) mode of action in the endoplasmic reticulum (ER) with an emphasis on the regulation of AGR2 dimers. Dysregulation of AGR2 dimer formation leads to inflammation as seen in inflammatory bowel disease (IBD) and Crohn's disease.

AGR2 is a chaperone involved in the regulation of protein quality control in the ER. We have developed and used a novel cellular proteinprotein interaction screen to identify cellular regulators of AGR2 dimerization.

We identify specific enhancers, including TMED2, and inhibitors of AGR2 dimerization, that control AGR2 functions.

Modulation of AGR2 dimer formation, whether enhancing or inhibiting the process, yields proinflammatory phenotypes, through either autophagydependent processes or secretion of AGR2, respectively.

In IBD and specifically in Crohn's disease, the levels of AGR2 dimerization modulators are selectively deregulated, and this correlates with severity of disease.

AGR2 dimers act as sensors of ER homeostasis which are disrupted upon ER stress and promote the secretion of AGR2 monomers. The latter might represent systemic alarm signals for proinflammatory responses.

EMBO Mol Med (2019) e10120

This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Marion Maurel, Joanna Obacz, Tony Avril, YongPing Ding, Olga Papadodima, Xavier Treton, Fanny Daniel, Eleftherios Pilalis, Johanna Hrberg, Wenyang Hou, MarieClaude Beauchamp, Julien TourneurMarsille, Dominique CazalsHatem, Lucia Sommerova, Afshin Samali, Jan Tavernier, Roman Hrstka, Aurlien Dupont, Delphine Fessart, Frdric Delom, Martin E FernandezZapico, Gregor Jansen, Leif A Eriksson, David Y Thomas, Loydie JeromeMajewska, Ted Hupp, Aristotelis Chatziioannou, Eric Chevet, Eric OgierDenis

Link:
Home | EMBO Molecular Medicine

Accornero, Federica

Mechanisms underlying heart and skeletal muscle diseases, with a primary focus on the role of RNA-binding proteins in regulating the expression of pathologic genes during stress challenges.

Ackermann-Borzok, Maegen

My research interests focus on the intricate structural organization and functionality of striated muscle physiology and pathophysiology. Specifically, we focus on 1. the intercalated discproteome and its role maintaining the synchronus beating of the heart and2. the role of novel obscurins, a family of cytoskeletal and signaling proteins,in cardiac and skeletal muscle.

Basu, Sujit

Angiogenesis and vasculogenesis; tumor microenvironment including cancer stem cells; preclinical cancer chemotherapy; neural immune cross talk in cancer.

Biesiadecki, Brandon

Understanding the molecular mechanisms of how muscle protein post-translational modifications (phosphorylation, radical modification, degradation, etc) alter heart function.

Brigstock, David

Characterization of connective tissue growth factor: structure-function analysis and role in fibrotic disease.

Burd, Craig

Steroid hormones signal through proteins that are able to bind DNA and initiate transcriptional programs. These transcription factors are critical mediators of virtually all physiological processes and are often deregulated in diseases such as cancer. The focus of my research is to dissect the molecular mechanisms controlling these factors activity with a particular interest in chromatin/epigenetic regulation.

Burghes, Arthur

Genetics of motor neuron disorders and the muscular dystrophies.

Byrd, John

The Byrd laboratory is focused on the 1) study of molecular and immune pharmacology in hematologic malignancies and 2) biology of malignant leukemia B-cell transformation. Our group is involved in identifying new targets for therapeutic exploitation and translating several novel targeted therapies and antibody based treatments from the lab to the clinic.

Davis, Jonathan

Dr. Davis lab focuses on the cellular and molecular basis of muscle contraction and relaxation via understanding how calcium binding proteins/enzymes are appropriately tuned kinetically to respond to calcium transients in vitro and in vivo. One of the laboratory goals is to modulate cellular function through the design and engineering of calcium binding proteins.

Doseff, Andrea

Mechanisms involved in cell death during the innate immune response and oncogenic transformation.

Drew, Mark

Genetic, cell biological, and biochemical studies of the protozoan parasite Plasmodium falciparum in an effort to discover novel therapeutics to treat human malaria.

Ganju, Ramesh

Chemokine-mediated breast cancer progression and metastasis; molecular mechanism of chemokine receptor CXCR4/CCR5-mediated pathogenesis during HIV infection; small molecular weight inhibitors for chemokine receptors and characterizing cross-talk between Slit/Robo and chemokine receptor pathways as a novel target for combating breast cancer metastasis and HIV infection.

Garzon, Ramiro

My lab is focusing on understanding the role of non coding RNAs in leukemogenesis and acute graft versus host disease.

Ghoshal, Kalpana

Role of DNA methylation and microRNAs in liver disease.

Guo, Peixuan

Dr. Guo's lab is really interdisciplinary with diverse technologies and variable projects involving the areas of cell biology, molecular medicine, virology, biophysics, biotechnology, biochemistry, chemistry, computation, biomedical engineering, single molecular optics, single molecular conductance, single pore sensing, RNA Nanotechnology, nucleic acid chemistry, cancer therapy, drug delivery, viral DNA packaging, and ATPase motors. The lab has been focused on the study of viral DNA packaging motor that is composed of a protein channel driven by six ATPase and geared by six RNA molecules.

Guttridge, Dennis

NF-kappa regulation of cell growth and differentiation.

Hai, Tsonwin

Eukaryotic gene expression, stress responses, cell death (apoptosis), cell cycle regulation, signal transduction, molecular mechanisms of diseases including cancer, diabetes and liver dysfunction. Experimental systems include cell free system, cell culture, transgenic and knock-out mice models.

Harper, Scott

Gene therapy for dominant genetic diseases using RNA interference (RNAi), with particular focus on muscular dystrophy and neurodegenerative disease.

Herman, Paul

Eukaryotic cell proliferation; ras protein signaling; RNA pol II transcription.

Ibba, Michael

Our research is directed towards understanding the mechanisms that determine how cells ensure the accurate translation of the genetic code, and how changes in the underlying processes impact cellular health and contribute to microbial pathogenesis and disease. Many of these processes are essential and unique to particular systems, making them ideal potential drug targets.

Jacob, Naduparambil

Radiation therapeutics, mechanisms of radiation resistance in cancers, cancer metastasis.

Janssen, Paul

Muscle mechanics. EC coupling and energetics of cardiac muscle tissue, under physiological and pathophysiological conditions.

Jhiang, Sissy

Protein tyrosine kinases and cancers; transgenic mice for human diseases; gene transfer of sodium/iodide symporter for radioiodine treatment in human cancers.

Kaspar, Brian

Investigation of cell death pathways in Central Nervous System Disorders; delivery of Gene Therapy Vectors to the CNS; identification of Neural Stem Cell Signaling Pathways and Development.

Kirschner, Lawrence

Molecular events leading to the formation of tumors of the endocrine glands, and the relationship of these processes to the differentiation of these tissues.

Kudryashov, Dmitri

Actin is an abundant eukaryotic protein involved in a variety of vital cellular events including, but not limited to cell migration, cytokinesis, endo- and exocytosis, organelle transport, and muscle contraction. We are interested in deciphering molecular and cellular mechanisms of actin-based processes, their regulation by actin binding proteins and disruption by bacterial and viral pathogens.

Lee, Robert

Targeted drug delivery systems for cancer. Gene therapy. Antisense and siRNA therapy. Liposomes and nanoparticles for drug delivery. Nanoparticle based nanomedicines. Immunotherapy for cancer.

Lesinski, Gregory

Research focuses on understanding the interactions between the host immune system and tumor cells. Ultimate goal is to develop novel therapeutic or chemo-preventative approaches to help patients with cancer and improve existing therapies. Inhibition of the oncogenic STAT3 pathway and maximizing the effect of immune based therapy are of particular interest.

Lessnick, Stephen

My research takes a translational approach to Ewing sarcoma, with the overarching goal of applying basic science discoveries to the clinical care of patients with this disease. We therefore have a significant focus on the basic biology of Ewing sarcoma, including the function of the EWS/FLI oncoprotein as a transcription factor, the associated epigenetic effects mediated by the fusion protein, and the phenotypic consequences mediated by EWS/FLI and its target genes important for the development of this disease. We use a number of techniques, including high-throughput genomics, molecular biology, and biochemistry, to accomplish these goals. We strive to translate these findings to patients, by assessing whether new discoveries might serve as critical nodes needed for tumor development. For example, the lysine specific demethylase 1 (LSD1) enzyme is required for the transcriptional function of EWS/FLI. We have been studying LSD1 inhibitors as potential therapies for Ewing sarcoma by analyzing the effects of LSD1 blockade on transcription, phenotype, and ultimately tumorigenesis both in vitro and in vivo. Finally, we also analyze patient specimens as a means to validate our laboratory-based studies; these samples also provide us with new hypotheses to study in the lab. Together, this philosophy and approach allow us to take a comprehensive approach to understanding this disease, and in doing so, to make an impact on patients with this highly-aggressive pediatric and young-adult cancer.

Lilly, Brenda

The Lilly lab studies mechanisms of blood vessel formation and smooth muscle differentiation. Our specific interests include endothelial and smooth muscle cell interactions, mechanisms of Notch signaling, and transcriptional control of smooth muscle gene expression.

Lincoln, Joy

Focus is on understanding embryonic origins of adult heart disease, with a specific interest in heart valves. Lab uses in vitro and in vivo tools in combination with molecular biology, bioengineering and imaging skills to examine the mechanisms of how heart valves form in the developing embryo, and how alterations in embryogenesis give rise to dysfunctional heart valves after birth.

Martin, Paul

Research in the Martin lab is focused on the role of glycoyslation in synapse formation and muscular dystrophy. Other studies involve understanding the role of carbohydrates in the development of the brain, and the development of diagnostic and therapeutic reagents for Alzheimer's disease.

Mathe, Ewy

My goal is to develop and apply analytical methods in genomics, epigenomics, and metabolomics to carefully characterize disease, cancer especially, at a molecular level. Please visit my website at u.osu.edu/mathelab for current research and news.

McBride, Kim

Focus is on elucidating causes of cardiovascular malformations, with the goal of developing novel therapies. We apply a variety of human genetic techniques (linkage, association, sequencing) to identify and characterize candidate genes. Functional consequences are studied in cell based systems. We use genetic and environmental models to examine cardiovascular developmental biology in the mouse.

McCarty, Douglas

The biology of adeno-associated virus (AAV), and its used as a gene delivery system for the treatment of human disease.

McHugh, Kirk

The research efforts in my laboratory rely upon an integrated scientific approach that is designed to identify the genetic pathways responsible for the ontogenesis and pathogenesis of smooth muscle tissues. The dysregulation of smooth muscle differentiation represe.

Mehta, Kamal

Signaling and transcriptional mechanisms regulating cholesterol homeostasis.

Muthusamy, Natarajan

Research interests are focused on the following areas: 1) Biological therapies for hematological malignancies with primary focus on acute and chronic leukemia; 2) Development and characterization of clinically relevant animal models of lymphoid malignancies; 3) Targeted delivery of RNA based therapeutics in lymphoid and myeloid malignancies.

Mykytyn, Kirk

Molecular genetics of complex diseases.

Niewiesk, Stefan

Immune modulation by measles virus and vaccination in the presence of maternal antibodies.

Partida-Sanchez, Santiago

Chemokine receptor signaling, generation of calcium second messengers, activation of calcium channels and their role in regulating migration of immune cells.

Pierson, Christopher

Elucidate the pathogenesis of the centronuclear myopathies, especially X-linked myotubular myopathy, and to develop novel therapies for these myopathies.

Rafael-Fortney, Jill

Mouse models of neuromuscular diseases.

Rosol, Thomas

The laboratory utilizes mouse models of human cancer to investigate the role of parathyroid hormone-related protein in bone metastasis and cancer-associated hypercalcemia. Metastases are monitored using in vivo bioluminescence of luciferase-transfected tumor cells. Molecular studies are focused on the regulation of PTHrP mRNA stability by transforming growth factors.

Schwab, Jan

My research aims to better understand and treat the maladaptive immune response after spinal cord injury. This is composed of i) the systemic spinal cord injury-induced immune deficiency syndrome (SCI-IDS), ii) consecutive infections and ii) the developing post-traumatic autoimmunity. Both maladaptive neuro-immunological syndromes and their consequences are contributing to the underlying neuropathology and represent a candidate target to improve neurological recovery.

Sen, Chandan

MicroRNA biology, tissue injury and repair, regenerative medicine, nutrition, oxygen and hypoxia, wound healing, stroke and neurodegeneration, myocardial infarction.

Shields, Peter

The Shields laboratory focuses on carcinogenesis, cancer risk and the development of new biomarkers for cancer risk. This involves a combined laboratory and epidemiology research program. The current emphasis is on diet and lifestyle, and using various omics technologies.

Stanford, Kristin

My research program will focus on novel molecular mechanisms of exercise to improve metabolic health. This will be broken down into three different aspects; exercise-induced adaptations to white and brown adipose tissue, the effects of parental exercise on the metabolic health of offspring, and the effects of exercise to improve the hypermetabolic response to burn injury.

Sun, Qinghua

Air pollution, exercise, and ambient temperature changes and exposures on human health, especially pulmonary and cardiovascular diseases and cancer.

Toland, Amanda

Identification and characterization of low penetrance cancer susceptibility genes.

The rest is here:
Molecular Medicine | Molecular, Cellular and Developmental ...

This interdepartmental study program is designed to provide third year medical students with an in-depth basic science or translational research experience in oncological sciences, regenerative medicine, the nutritional and metabolic mechanisms of chronic disease or the molecular basis of disease. Faculty members in this study track come from numerous departments, including Medicine, Biochemistry, Cell Biology, Immunology, Pathology, and Pharmacology and Cancer Biology.

Students who elect this study program undertake a research project in a laboratory under the guidance of a faculty preceptor and participate in appropriate seminar series. In addition, with the permission of their mentor and study program director, students may take course work each term to complement their research interests. Due to the wide range of research opportunities available, course work is individually tailored to the interests of the student by the faculty preceptor. There are five(5) discreet sub tracks to accommodate the diversity of interest in Molecular Medicine

David Hsu, M.D., Ph.D., Director

Read the original here:
Molecular Medicine (MolMed) | Duke School of Medicine

The Department of Molecular Medicine is actively engaged in research and education to build a premier virus, gene and cell therapy program and to translate promising therapeutics from bench to bedside in a timely manner.

The wide range of disciplines represented the Department of Molecular Medicine's leadership team and staff facilitates a breadth of translational activities. The researchers in the Department of Molecular Medicine are in the unique position of being able to move a basic science discovery all the way through to clinical trials and the development of novel therapies, all within the department and in an expedited fashion. For instance, instead of the standard five- to seven-year industry time frame, the department has moved their attenuated measles virus therapy for ovarian cancer from discovery to clinical trials within three years. This integrated process enables the advancement of science and the quick delivery of new treatments to patients.

Researchers from the Department of Molecular Medicine participate in achieving the center's goal of personalizing each person's treatment for optimal care. The Molecular Medicine department's research team is focused on advancing the center's research into biomarker discovery. Researchers are also actively involved in applying their expertise in gene therapy to the field of regenerative medicine, particularly in the areas of beta cell regeneration and liver regeneration.

The Department of Molecular Medicine works with the Gene and Virus Therapy Program of the Mayo Clinic Cancer Center Research to develop new gene delivery systems and gene and virus-based therapies for cancer treatment. The program conducts research on all Mayo Clinic campuses. The Gene and Virus Therapy Program focuses on four areas of research:

Core facilities such as the Viral Vector Production Laboratory and the Toxicology and Pharmacology Shared Resource manufacture clinical-grade engineered viruses and perform preclinical toxicology and biodistribution studies to support the department's clinical trials.

View original post here:
Molecular Medicine Research - Mayo Clinic Research

Professor & Lucille P. Markey Chair

The Department of Biochemistry and Molecular Biology at the University of Miami is committed to maintaining our discipline as a central science and strives for excellence by sustaining the current areas of strength, fostering interdisciplinary and clinical translational research, and expanding the research portfolio to evolving areas of inquiry and discovery. Our expertise in RNA biology, understanding DNA stability and repair, studying the biophysical nature of biomolecules, and gaining insight into cellular signaling pathways has been recently expanded by the arrival of researchers specialized in the design of natural and semi-synthetic biomolecules, as well as molecular-based devices that can be employed in translational medicine and other bionanotechnology applications. The commitment of the Miller School to increase growth in the basic sciences will continue to provide our Department with new and exciting opportunities to enhance our prominence in biomedical research.

A chief mission of our Department is to educate future generations of investigators and medical students to become critical thinkers and the leaders in their fields. The diverse composition of our Department in regards to research interests creates a unique and intellectually stimulating learning environment for students at the undergraduate, graduate, and postgraduate levels. We offer a host of courses to fulfill the curriculum to obtain a B.S. in Biochemistry, a MS and a Ph.D. in Biochemistry, as well as the basic science requirements for MD and MD/Ph.D. students. Our courses address both the basic principles of biochemistry and molecular biology as well as the emerging science and future of the fields.

The Department serves the worldwide scientific community through leadership roles and active participation in national and international conferences, serving in study sections and on federal agency panels. Additionally, our Departments faculty roster encompasses editors of journals and members of editorial boards, as well as board members of national and international governmental centers and members of advisory boards of companies in the private sector. Moreover, the Department is committed to serve the community by participating in a variety of outreach events to promote awareness of the importance of science and technology in relation to public health and the environment.

Our Department is also unique for hosting the internationally recognized annual Miami Winter Symposium, created by Professor William Whelan, the first leader and Chair of the Department. The Miami Winter Symposium is currently managed by Elsevier and features world-renowned speakers in emerging areas of science and technology. This event cements our Departments goal of furthering education and discovery in biochemistry and molecular biology on an international level.

Dr. Sylvia DaunertProfessor and Lucille P. Markey ChairDepartment of Biochemistry & Molecular Biology

Read more:
Biochemistry and Molecular Biology at Miller School of ...

OverviewConditions of admissionScholarshipApplications

Overview

The overall objective is an in-depth education of molecular and cellular basics in the operation of the human organ system as well as pathogenesis and therapy of human diseases. One focus of the education will be in the fields of drug research, cardiovascular research and oncology/immunology. Through broad professional education and teaching of different methodical and conceptional areas, students will learn to individually perform research in basic sciences as well as clinical-translational research (klinisch-translationale Forschung) in molecular medicine. The Masters program in molecular medicine will convey students the required knowledge and skills, train individual scientific thinking and lead to responsible behavior as a Scientist.

Information from the departmentStudy regulationsFirst Amendment of regulations

Master of Science Molecular Medicine

The standard length of study for the Master of Science degree is 4 semesters.

German and English

The study programme starts at the beginning of the winter semester.

Kristine KuschinskiE-Mail: kristine.kuschinski@kgu.de

to the top

Conditions of admission

If the university entrance qualification for the consecutive Masters programme (namely the Bachelors degree) has not yet been completed, you can apply for the programme with a transcript of records on the basis of at least 144 credit points. This provisional certificate must be issued by an office authorised to award grades or issue certificates. If a student is admitted, this will be on a provisional basis.

to the top

Scholarship

to the top

Applications

01.05. - 15.06.

Online applicationportal for Masters programmes

to the top

Original post:
Goethe-Universitt Molecular Medicine (Master of Science)

Rong Li, Ph.D.

Professor

Profile and Contact Information | Research | Laboratory

RESEARCH

Our laboratory addresses the following three fundamental questions concerning breast cancer treatment and prevention.

1. How does BRCA1 suppress tumor development in a gender- and tissue-specific manner? Women who carry cancer-predisposing germ-line mutations in BRCA1 have significantly increased chance of developing breast and ovarian cancers. While the BRCA1 activity in DNA repair is clearly important to the etiology of BRCA1-associated cancers, it is not clear whether the DNA repair function alone is sufficient to account for the gender- and tissue-specific tumor suppression by BRCA1. We previously identified a BRCA1-binding protein COBRA1, which is identical to the B subunit of NELF involved in pausing of RNA polymerase II. Using mouse genetics and clinical samples from BRCA1 mutation carriers, we are investigating whether a crosstalk between BRCA1 and COBRA1-regulated transcription machinery contributes to the tissue-specific function of BRCA1 in breast epithelium.

2. How can the antitumor activity of estrogen receptor (ER) be mobilized?In contrast to the tumor-promoting activity of ER, ER inhibits tumor growth in breast cancer. Because ER is present in a significant percentage of breast cancer cases, rallying its antitumor activity could serve as a potential therapeutic approach. Our pioneer discovery of a phosphotyrosine switch for the antitumor activity of ER enables us to mobilize ER function with unprecedented precision. We are testing the hypothesis that turning on this molecular switch of ER can inhibit triple negative breast cancer and circumvent hormonal resistance of ER-positive breast cancer, two clinically pressing areas where therapeutic potential of ER has been previously demonstrated.

3. How do adipose stromal cells (ASC) promote breast cancer progression?ASC is a major constituent of the breast and a source of tumor-promoting factors including estrogens. We recently discovered a new mechano-transducing pathway that links mechanical phenotype with the endocrine/paracrine output of ASCs. This pathway is initiated by a cell surface receptor called discoidin domain receptor 1 (DDR1). Combining three-dimension cell culture systems and animal models, we are exploring novel therapeutic approaches to disrupt this stroma-tumor communication.

Selected Publications

Complete list of published work.

Read more:
Faculty Research - Department of Molecular Medicine ...

The Section of Molecular Medicine focuses on performing cutting-edge research in cellular and molecular mechanisms of human disease and supports graduate and postgraduate level educational programs within the Department of Internal Medicine.

A major goal of the section is to serve as a nidus for translational research by providing an environment where clinical and basic science faculty interact to make new discoveries and to educate future scientists.

The section consists of 24 primary faculty members and two emeritus faculty members who use cellular and molecular approaches to gain a better understanding of the basic mechanisms underlying acute and chronic human conditions, including sepsis, arthritis, atherosclerosis, diabetes, obesity, fatty liver, and cancer.

Molecular Medicine faculty collaborate on forward (disease/phenotype -> molecule) and reverse (molecule mutation/deletion -> disease phenotype) translational research to bidirectionally link new molecule discovery to disease pathogenesis using state-of-the-art omics (transcription, epigenetics, proteomics, metabolomics, lipidomics) and gene editing/deletion/overexpression technologies.

The Molecular Medicine Section is the academic home for the Molecular Medicine and Translational Science (MMTS) graduate program, one of the largest biomedical sciences graduate programs at Wake Forest University. MMTS offers PhD and MS training for BS, MD and DVM students. The section also provides laboratory research training and education in translational research for medical students, residents and postdoctoral fellows, including subspecialty fellows in the Department of Internal Medicine. A seminar series and journal club are held weekly as part of the training program in MMTS.

We invite you to explore our department and contact us with any questions you may have.

See the original post:
Section of Molecular Medicine | Wake Forest School of Medicine

Welcome Message

On behalf of the Scientific Committee, we are honored to invite you to12thInternational Conference and Expo on Proteomics and Molecular Medicineto be held inDublin, IrelandduringNovember 26-28, 2018.

The Theme of theProteomics and Molecular Medicine 2018is Solving problems in Proteomics, Biology and Medicine" which covers wide range of critically important sessions in the field of Proteomics, Molecular Medicine, Mass Spectrometry, Protein Analysis, Biochemistry, Bioinformatics, Molecular Diagnostics, Molecular Devices, Molecular Biology and Pathology. Objective of this meeting is to share the foremost updated knowledge in the field of proteomics, drug discovery, development and diagnostics. We will gather academicians and young inspired scientists from all around the world involved in researches at the cutting edge in the study of the proteomics and molecular medicine.

The conference proceedings will include Keynote/plenary Sessions, Oral Presentations, Seminars, Symposiums, Workshops, Young Researchers Forums and Posters Presentations on the latest treatment innovations in the field ofMolecular Medicine,Diagnostics and the advancements in Proteomics, BioinformaticsandMass spectrometryby experts from both academic and business background.

It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Proteomics and Molecular Medicine.

Proteomics and Molecular Medicine 2018committed to create real and reliable contributions to the scientific community.Conference Series llc LTDorganize 2000+ Conferences once a year across USA, Canada , Europe, Middle East & Asia with support from a thousand additional scientific societies and Publishes 900+ Open access journals that contains over thousands eminent personalities, putative scientists as editorial board members.

Why to attend??

Encounter the target market with members from across the globe, committed to learn about Proteomics and Molecular Medicine. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations, distribute and update knowledge about Proteomics and Molecular Medicine and receive name recognition at this 3-days event. World-eminent speakers, most recent researches, latest treatment techniques and theadvanced updates in protein analysis, mass spectrometry, molecular diagnostics and devices are the principal features of this conference.

Target Audience:

Our Organization would be privileged to welcome the:

Highlights of latest advances on Proteomics and Molecular Medicine 2018

Track: 1Proteomics from Discovery to Function

Proteomicsis an emerging field that has been highly enabled by the human genome project. Proteins are the products of genes, the machinery of the cells in our bodies. When genes are disrupted, theproteinsare also affected. Whenpathogensinfect us, causing disease, proteins play a key role in signaling the presence and ridding us of these invaders. Almost every process that occurs in our cells from the metabolization of simple sugar to the division of cells is dependent on proteins for smooth operation. In general,proteomicsseeks to detect and quantify as many proteins as possible.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress - Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Human Proteome Organization, European Proteomics Association (Eupa), Spanish Proteomics Society (Seprot), Netherlands Proteomic Platform (Npp), Japan Human Proteome Organisation (Jhupo), Italian Proteomic Association (Itpa), Portugese Proteomic Association (Rede Procura), Iranian Proteomic Society, Taiwan Proteomic Society (Tps), Austrian Proteomics Society, European Proteomics Association, British Mass Spectrometry Society, Belgian Mass Spectrometry Society, Danish Mass Spectrometry Society

Track: 2Mass Spectrometry in Proteome Research

Mass spectrometry(MS) - based proteomics allows the sensitive and accurate quantification of almost complete proteomes of complex biological fluids and tissues. At the moment, however, the routinely usage of MS-based proteomics is prevented and complicated by the very complex work flow comprising sample preparation,chromatography, MS measurement followed by data processing and evaluation. The new technologies, products and assays developed byPrecision Proteomicscould help enabling and establishing mass spectrometry (MS) - based proteomics in academic andpharmaceutical proteomicsresearch as well as in clinical diagnostics.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress - Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Australian and New Zealand Mass Spectrometry Society, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Association for Molecular Pathology, Molecular and Cellular Cognition Society, Hong Kong Society For Molecular Diagnostic Sciences Limited, Biochemical Society, Society for Molecular Biology & Evolution, The French Society for Biochemistry and Molecular Biology, The German Society for Biochemistry and Molecular Biology, Molecular Biology Society of Japan, Society of Nuclear Medicine and Molecular Imaging

Track: 3Proteomics and Molecular Medicine

Molecular Medicinepromotes the thoughtful of biological mechanism of disease at the cellular and molecular levels for enhanced diagnoses, treatment, and prevention of disease. Proteomics plays an important role in medical research and molecular medicine, such as in drug discovery anddiagnostics, because of the link between proteins, genes anddiseases, and it is considered to be the next step in modern biology. Proteomics is dynamic compared to genomics because it changes constantly to reflect the cells environment. The main objectives in the arena of proteomics are; identifying all proteins, analyse differentialprotein expressionin different samples, characterise proteins by identifying and studying their function and cellular localisation, and recognize protein interaction networks.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress - Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Human Proteome Organization, European Proteomics Association (Eupa), Spanish Proteomics Society (Seprot), Netherlands Proteomic Platform (Npp), Japan Human Proteome Organisation (Jhupo), Italian Proteomic Association (Itpa), Portugese Proteomic Association (Rede Procura), Iranian Proteomic Society, Taiwan Proteomic Society (Tps), Austrian Proteomics Society, European Proteomics Association, British Mass Spectrometry Society, Belgian Mass Spectrometry Society, Danish Mass Spectrometry Society

Track: 4Molecular Medicine and Diagnostics

Molecular diagnosticsis prominent disruptive innovation in healthcare by the introduction of many tools that are having a profound impact onhealthcaredelivery. These includenext-generation sequencing, wearable sensors, liquid biopsies, direct-to-consumer testing, point-of-care assays, and early cancer detection. Join industry leaders at the molecular diagnostics event to discuss recent developments and decipher how changes in regulation, reimbursement, and implementation guidelines will impact progress in new markets created by innovations in this technology.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress - Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Australian and New Zealand Mass Spectrometry Society, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Association for Molecular Pathology, Molecular and Cellular Cognition Society, Hong Kong Society For Molecular Diagnostic Sciences Limited, Biochemical Society, Society for Molecular Biology & Evolution, The French Society for Biochemistry and Molecular Biology, The German Society for Biochemistry and Molecular Biology, Molecular Biology Society of Japan, Society of Nuclear Medicine and Molecular Imaging

Track: 5Molecular Diagnostics and Devices

Molecular diagnosticsand devices are enabling precise diagnosis and treatment ofoncology, infectious disease and immunotherapy. Experts in the arena will highlight the latest tools, clinical advances, besides commercial applications of circulating and tissue-based biomarkers that are transformingmedicine.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress - Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Human Proteome Organization, European Proteomics Association (Eupa), Spanish Proteomics Society (Seprot), Netherlands Proteomic Platform (Npp), Japan Human Proteome Organisation (Jhupo), Italian Proteomic Association (Itpa), Portugese Proteomic Association (Rede Procura), Iranian Proteomic Society, Taiwan Proteomic Society (Tps), Austrian Proteomics Society, European Proteomics Association, British Mass Spectrometry Society, Belgian Mass Spectrometry Society, Danish Mass Spectrometry Society

Track: 6Protein Expression and Analysis

Protein expressionrefers to the way in which proteins are synthesized, modified and regulated in living organisms. In protein research, the term can apply to either the object of study or the laboratory techniques required to manufacture proteins.Protein analysisis thebioinformaticsstudy of protein structure,protein interactionand function using database searches, sequence comparisons, structural and functional predictions.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress - Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Australian and New Zealand Mass Spectrometry Society, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Association for Molecular Pathology, Molecular and Cellular Cognition Society, Hong Kong Society For Molecular Diagnostic Sciences Limited, Biochemical Society, Society for Molecular Biology & Evolution, The French Society for Biochemistry and Molecular Biology, The German Society for Biochemistry and Molecular Biology, Molecular Biology Society of Japan, Society of Nuclear Medicine and Molecular Imaging

Track: 7Proteomics and its Medicinal Research

Personalised medicineaims to tailor treatments to achieve the best outcome for individual patients, rather than treating patients with a one size fits all approach. Personalized medicine, also termedprecision medicine, is a medical procedure that separates patients into different groupswith medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress - Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Human Proteome Organization, European Proteomics Association (Eupa), Spanish Proteomics Society (Seprot), Netherlands Proteomic Platform (Npp), Japan Human Proteome Organisation (Jhupo), Italian Proteomic Association (Itpa), Portugese Proteomic Association (Rede Procura), Iranian Proteomic Society, Taiwan Proteomic Society (Tps), Austrian Proteomics Society, European Proteomics Association, British Mass Spectrometry Society, Belgian Mass Spectrometry Society, Danish Mass Spectrometry Society

Track: 8Proteomics in Biochemistry and Molecular Biology

Biochemistryis the study of the structure and function of biological molecules such as proteins, nucleic acids, carbohydrates and lipids. Biochemistry is also used to describe techniques suited to understanding the interactions and functions ofbiological moleculesand it is a laboratory based science that brings together biology and chemistry. By using chemical knowledge and techniques, biochemists can understand and solve biological problems. Biochemistry focuses on processes happening at a molecular level and it focuses on whats happening inside our cells. It also looks at how cells communicate with each other, for example during growth or fighting illness. Medicine is a broad category but relates to biochemistry on many levels. Doctors and nurses give drugs to patients to help cure a disease or prevent it. This is since when thatdrugis added to the human system, it alters how other chemicals in the body function, resulting in disease prevention or recovery.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress - Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Australian and New Zealand Mass Spectrometry Society, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Association for Molecular Pathology, Molecular and Cellular Cognition Society, Hong Kong Society For Molecular Diagnostic Sciences Limited, Biochemical Society, Society for Molecular Biology & Evolution, The French Society for Biochemistry and Molecular Biology, The German Society for Biochemistry and Molecular Biology, Molecular Biology Society of Japan, Society of Nuclear Medicine and Molecular Imaging

Track: 9Precision Medicine and Immuno-Oncology

The significance and role of the human genome in thediagnosisand treatment of disease, they lay out the groundwork for precision or genomic medicine. In turn,immuno-oncologyresearches are changing the way we treat cancer by unleashing the immune system, and achieving better survival for many patients and cure for some. Covering latest advances in precision medicine,genomicsand genetics for drug discovery application, cancer immuno-therapy, biomarkers and translational strategies in immune-oncology, Precision Medicine and Immuno-Oncology tracks will bring together uppermost experts from industry and academia to discuss emerging trends and solutions in order to provide the most up-to-date, scientifically sound care for patients with cancer and chronic diseases.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress - Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Human Proteome Organization, European Proteomics Association (Eupa), Spanish Proteomics Society (Seprot), Netherlands Proteomic Platform (Npp), Japan Human Proteome Organisation (Jhupo), Italian Proteomic Association (Itpa), Portugese Proteomic Association (Rede Procura), Iranian Proteomic Society, Taiwan Proteomic Society (Tps), Austrian Proteomics Society, European Proteomics Association, British Mass Spectrometry Society, Belgian Mass Spectrometry Society, Danish Mass Spectrometry Society

Track: 10Proteomics in Computational Systems Biology

Systems biologyis an exciting new approach to understand biological complexity. It builds on large-scale measurement technologies, such asnext-generation sequencingandmass spectrometry.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress - Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Australian and New Zealand Mass Spectrometry Society, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Association for Molecular Pathology, Molecular and Cellular Cognition Society, Hong Kong Society For Molecular Diagnostic Sciences Limited, Biochemical Society, Society for Molecular Biology & Evolution, The French Society for Biochemistry and Molecular Biology, The German Society for Biochemistry and Molecular Biology, Molecular Biology Society of Japan, Society of Nuclear Medicine and Molecular Imaging

Track: 11Proteomics for Bioinformatics

Bioinformaticsis both an umbrella term for the body of biological studies that use computer programming as part of their methodology, as well as a reference to specific analysis "pipelines" that are repeatedly used, particularly in the fields of genetics andgenomics. Common uses ofbioinformaticsinclude the identification of candidate genes and nucleotides.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress - Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Human Proteome Organization, European Proteomics Association (Eupa), Spanish Proteomics Society (Seprot), Netherlands Proteomic Platform (Npp), Japan Human Proteome Organisation (Jhupo), Italian Proteomic Association (Itpa), Portugese Proteomic Association (Rede Procura), Iranian Proteomic Society, Taiwan Proteomic Society (Tps), Austrian Proteomics Society, European Proteomics Association, British Mass Spectrometry Society, Belgian Mass Spectrometry Society, Danish Mass Spectrometry Society

Track: 12Proteomics and its Research

Proteins provide most of themolecularmachinery of cells. Many areenzymesor subunits of enzymes. Other proteins play structural or mechanical roles, such as those that form the struts and joints of the cytoskeleton. Eachproteinis linear polymers built ofamino acids.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress - Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Australian and New Zealand Mass Spectrometry Society, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Association for Molecular Pathology, Molecular and Cellular Cognition Society, Hong Kong Society For Molecular Diagnostic Sciences Limited, Biochemical Society, Society for Molecular Biology & Evolution, The French Society for Biochemistry and Molecular Biology, The German Society for Biochemistry and Molecular Biology, Molecular Biology Society of Japan, Society of Nuclear Medicine and Molecular Imaging

Proteomics attribute to the study of proteomes, but is also used to characterize the techniques used to determine the complete set of proteins of an organism or system, such as protein purification and MS. Proteomics is a developing field that has been deeply enabled by the human genome project. Proteins which are the products of genes, the machinery of the cells in our bodies. When genes are disturbed, the proteins are also damaged. When pathogens infect us, causing disease, proteins play a major role in signaling the presence & ridding us of these invaders. Almost every process which that occurs in our cells from the metabolization of clean sugar to the distribution of cells is dependent on proteins for smooth operation. In general, proteomics seeks to distinguish & quantify as many proteins as possible likewise Molecular Medicine promotes the understanding of biological mechanism of disease at the cellular and molecular levels for better diagnoses, treatment, and prevention of disease. Proteomics plays an important role in medical research and molecular medicine, such as in drug discovery and diagnostics, because of the link between proteins, genes and diseases, and it is considered to be the next step in modern biology.

There are numerous advances in this proteomics innovation, especially in the field of sub-atomic science. New proteomics and genomics advancements and creations could be utilized for ailment particular biomarker revelation and to screen tolerant reaction to the treatment. Proteomics might likewise set up new, atomic order of the malady. Applying genomic and proteomic strategies to body liquids (serum, cerebrospinal liquid, pee, and so on.) and tissue concentrates would put profitable goal diagnostic force in the hands of the clinician however approval of those techniques is an imperative issue. The quick extension of the analytic apparatuses taking into account advancements in proteomic and genomic advances can be essential for the improvement of customized solution. As a science that studies interactions between the molecular components that carry out the various biological processes in living cells, an important idea in molecular biology states that information flow in organisms follows a one-way street: Genes are transcribed into RNA, and RNA is translated into proteins.

Why Dublin, Ireland?

Europe is one such region which encompasses the major share of the Proteomics and molecular medicine research which is mainly on ovarian cancer biomarker research. Dublin being one of the most advanced European economies is bound to hold the chief share in Europes Proteomics and molecular medicine market. Further as EU expands the research, export and trading relations are bound to enhance.

The globalproteomics marketis expected to reach over USD 24.8 billion by 2024 according to a new report by Grand View Research, Inc. The introduction of technology-enabled proteomics products is one of the high-impact rendering drivers for the proteomics market growth. These products find extensive applications in drug discovery, diagnostic services, and many other research areas. The increasing market penetration of these technologies, such as ESI-LC-MS (electrospray ionization liquid chromatography mass spectrometry), is expected to serve as a driver of this market.

Proteomics Market By Product, USD Million, 2013 - 2024

Theeurope molecular diagnostics marketis expected to reach USD4.0 billion by 2024, according to a new report by Grand View Research, Inc. Growing geriatric population and the increasing prevalence of neurological and cardiovascular disorders is expected to drive the growth of molecular diagnostics. Moreover, increasing demand for more efficient healthcare delivery to facilitate early diagnostics is further expected to boost market growth.

Molecular medicine, diagnostic market by application, 2013-2024USD Million

Proteomics Congress 2017

Conference Series llc LTDtakes a great pride in announcing the 9thInternational Conference & Expo on Proteomics and Molecular Medicine(Proteomics Congress 2017) which was held in Paris, France, during 13-15 November, 2017.

Proteomics Congress 2017 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of proteomics and molecular medicine. The extremely illustrious conference hosted byConference Series llc LTDwas marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 30 countries around the world.

The conference aimed a parallel rail with theme Novel Advancements in Proteomics and Molecular Medicine. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Mass spectrometry in Proteome Research, Protein Expression and Analysis, Proteomics from Discovery to Function, Molecular Medicine and Diagnostics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Proteomics, Molecular Medicine, Bioinformatics and Mass Spectrometry Technology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The Organizing Committee would like to thank the moderatorsDr. Oliva Petra from Sanofi Genzyme, USA, Dr. Marwa Eltoweissy, University of Gttingen, Germany for their contributions which resulted in smooth functioning of the conference.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The highlights of the conference were the keynote forum by prominent scientists,Boris Zaslavsky, Cleveland Diagnostics, USA;Bin Huang, Kaohsiung Medical University, Taiwan;Judit Ovdi, Hungarian Academy of Sciences, Hungary;Jarrod A Marto, Harvard Medical School, USA; Magnus S Magnusson, University of Iceland, Iceland; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series llc LTDis prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions, workshops and special sessions in a diversified and variegate manner to make this conference an enviable artifact.

Conference Series llc LTDoffers its heartfelt appreciation to the exhibitor Proteintech, collaborators Instruct Integrating Biology, European Biotechnology Network, Bilkent Genetik Toplulugu, Malaysian Biotechnology Information Center, Swiss Biotech Association & Human Behaviour Laboratory who supported the conference in every aspect for the awe-inspiring exhibition at the venue. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

Conference Series llc LTDcongratulates the best poster award winner Dr. Pratibha Sharma, All India Institute of Medical Sciences, India. We would also like to thank Dr. Jarrod A Marto, Harvard Medical School, USA and Dr. Pavlina Dolashka, Bulgarian Academy of Sciences, Bulgaria who supported us by evaluating the posters.

We once again thank all the participants for their wonderful contribution towards the event which helped us for successful accomplishment of this event.

Conference Series llc LTD9thInternational Conference & Expo on Proteomics and Molecular Medicine would not have been successful if it has not been supported by international, multi-professional steering committee and coordination of theJournal of Proteomics & Bioinformatics, Journal of Pharmacogenomics & Pharmacoproteomics & Journal of Data Mining in Genomics & Proteomics.

After the successful completion of eleven consecutive conferences we are overwhelmed to announce our next upcoming conferences which are going to be held in Europe is the 12thInternational Conference and Expo on Proteomics and Molecular Medicine which is going to be held during November 26-28, 2018 in Dublin, Ireland.

Conference Series llc LTDtakes a great pride in announcing the 7thInternational Conference & Expo on Proteomics(Proteomics Congress 2016) which was held in Rome, Italy, during 24-26 October, 2016.

Proteomics Congress 2016 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of proteomics. The extremely illustrious conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries around the world.

The conference aimed a parallel rail with theme Proteomics: An atlas of expression. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Proteomics from Discovery to Function, Mass Spectrometry in Proteome Research, Proteomics for Bioinformatics, Cancer and Clinical proteomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Proteomics, Bioinformatics and Mass Spectrometry Technology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The Organizing Committee would like to thank the moderatorsDr. Marwa Eltoweissy, University of Gttingen, Germany,Dr. Jill Barber, University of Manchester, UK for their contributions which resulted in smooth functioning of the conference.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The highlights of the conference were the keynote forum by prominent scientists,Boris Zaslavsky, Cleveland Diagnostics, USA;John F Cipollo, Center for Biologics Evaluation and Research-USFDA, USA;Stefan Kempa, Berlin Institute for Medical Systems Biology - MDC Berlin, Germany;Magnus S Magnusson, University of Iceland, Iceland; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series llc LTDis prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions, workshops and special sessions in a diversified and variegate manner to make this conference an enviable artifact.

Read more from the original source:
Proteomics Conferences 2018 | Molecular Medicine Congress ...

TRUE DISCOVERY AWAITS

It takes a certain mind to go in search of true discovery. In nuclear medicine, they are the clinical researchers looking to set new standards of care, the practitioners working to deliver better outcomes for the patients they see every day and the cardiologists seeking a better understanding of the heart. While they all have the same goal, their needs are different and cant all be met with one system or technology.

Nuclear medicine is an excellent choice for physicians at the forefront of medicine. It has a wide range of available radioisotopes with various energy emission levels and longer half-lives. It also has the flexibility to explore multiple pathways in a single session. These are some of the reasons why we made a commitment to realizing the full potential of and growing this modality.

This commitment involves making nuclear medicine technology more accessible and enabling it to provide results that are more valuable to referring physicians. It means driving down daily operational costs and innovating in four key areas: image quality, dose reduction, exam speeds and quantitative applications. All with the end result of enabling better clinical and economic outcomes.

It also includes our vision for a fully digital nuclear medicine experience. An experience that starts with best-in-class hardware and software that collects your data in the cloud and then converts that data into actionable insights through deep learning and analytics. All of our systems are designed to leverage this fully digital vision right away. If you are interested in digital detection technology as well, you can choose between a system already fitted with CZT-based digital detectors or an adaptable, digital-detection-ready system.

No matter what nuclear medicine technology you choose, you will have the tools you need to go in search of true discovery.

Accurate quantitation

High image quality

Short exams

Dose efficiency

Expanded access

Fully digital experience

Excerpt from:
Nuclear Medicine - Molecular Imaging - Nuclear Medicine ...